Impact of in vivo chronic blockade of adenosine A2A receptors on the BDNF-mediated facilitation of LTP

Neuropharmacology

Volumn 83, Issue , 2014, Pages 99-106

  Jerónimo Santos, André ^a,b   Batalha, Vânia L ^b   Müller, Christa E ^c   Baqi, Younis ^c,d   Sebastião, Ana Maria ^a,b   Lopes, Luisa V ^b   Diógenes, Maria José ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c UNIVERSITY OF BONN   (Germany)

^d SULTAN QABOOS UNIVERSITY   (Oman)

Author keywords

Alzheimer's disease; Istradefylline; KW 6002; TrkB

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; ISTRADEFYLLINE; MESSENGER RNA; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; PURINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EX VIVO STUDY; FACILITATION; HIPPOCAMPAL CA1 REGION; IN VIVO STUDY; LONG TERM POTENTIATION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; ANIMAL; DRUG EFFECTS; METABOLISM; WISTAR RAT;

ADENOSINE A2 RECEPTOR ANTAGONISTS; ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CA1 REGION, HIPPOCAMPAL; LONG-TERM POTENTIATION; MALE; PURINES; RATS; RATS, WISTAR; RECEPTOR, ADENOSINE A2A; RECEPTOR, TRKB;

EID: 84899579498     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2014.04.006     Document Type: Article

References (57)

1. S.J. Allen, G.K. Wilcock, and D. Dawbarn Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease Biochem. Biophys. Res. Commun. 264 1999 648 651
2. G.W. Arendash, W. Schleif, K. Rezai-Zadeh, E.K. Jackson, L.C. Zacharia, J.R. Cracchiolo, D. Shippy, and J. Tan Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production Neuroscience 142 2006 941 952
3. R.I. Aroeira, J.A. Ribeiro, A.M. Sebastiao, and C.A. Valente Age-related changes of glycine receptor at the rat hippocampus: from the embryo to the adult J. Neurochem. 118 2011 339 353
4. V.L. Batalha, J.M. Pego, B.M. Fontinha, A.R. Costenla, J.S. Valadas, Y. Baqi, H. Radjainia, C.E. Muller, A.M. Sebastiao, and L.V. Lopes Adenosine A(2A) receptor blockade reverts hippocampal stress-induced deficits and restores corticosterone circadian oscillation Mol. Psychiatry 18 2013 320 331
5. V.L. Batalha, J.S. Valadas, Y. Baqi, H. Radjainia, and L.V. Lopes Adenosine A2A receptor activation-trigger to aging-like modifications on adenosine modulation in the hippocampus J. Neurochem. 125 2013 153
6. M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N.A. Castello, F.J. Muller, J.F. Loring, T.R. Yamasaki, W.W. Poon, K.N. Green, and F.M. LaFerla Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 106 2009 13594 13599
7. P.M. Canas, L.O. Porciuncula, G.M. Cunha, C.G. Silva, N.J. Machado, J.M. Oliveira, C.R. Oliveira, and R.A. Cunha Adenosine A2A receptor blockade prevents synaptotoxicity and memory dysfunction caused by beta-amyloid peptides via p38 mitogen-activated protein kinase pathway J. Neurosci. 29 2009 14741 14751
8. H.C. Cheng, H.M. Shih, and Y. Chern Essential role of cAMP-response element-binding protein activation by A2A adenosine receptors in rescuing the nerve growth factor-induced neurite outgrowth impaired by blockage of the MAPK cascade J. Biol. Chem. 277 2002 33930 33942
9. B. Connor, D. Young, Q. Yan, R.L. Faull, B. Synek, and M. Dragunow Brain-derived neurotrophic factor is reduced in Alzheimer's disease Brain Res. Mol. Brain Res. 49 1997 71 81
10. R.A. Cunha, M.D. Constantino, and J.A. Ribeiro ZM241385 is an antagonist of the facilitatory responses produced by the A2A adenosine receptor agonists CGS21680 and HENECA in the rat hippocampus Br. J. Pharmacol. 122 1997 1279 1284
11. R.A. Cunha, B. Johansson, B.B. Fredholm, J.A. Ribeiro, and A.M. Sebastiao Adenosine A2A receptors stimulate acetylcholine release from nerve terminals of the rat hippocampus Neurosci. Lett. 196 1995 41 44
12. O.P. Dall'Igna, P. Fett, M.W. Gomes, D.O. Souza, R.A. Cunha, and D.R. Lara Caffeine and adenosine A(2a) receptor antagonists prevent beta-amyloid (25-35)-induced cognitive deficits in mice Exp. Neurol. 203 2007 241 245
13. R. Deogracias, G. Espliguero, T. Iglesias, and A. Rodriguez-Pena Expression of the neurotrophin receptor trkB is regulated by the cAMP/CREB pathway in neurons Mol. Cell. Neurosci. 26 2004 470 480
14. L. Devi, and M. Ohno 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease Neuropsychopharmacology 37 2012 434 444
15. P.A. Dijkhuizen, and A. Ghosh BDNF regulates primary dendrite formation in cortical neurons via the PI3-kinase and MAP kinase signaling pathways J. Neurobiol. 62 2005 278 288
16. M.J. Diogenes, C.C. Fernandes, A.M. Sebastiao, and J.A. Ribeiro Activation of adenosine A2A receptor facilitates brain-derived neurotrophic factor modulation of synaptic transmission in hippocampal slices J. Neurosci. 24 2004 2905 2913
17. M.J. Diogenes, N. Assaife-Lopes, A. Pinto-Duarte, J.A. Ribeiro, and A.M. Sebastiao Influence of age on BDNF modulation of hippocampal synaptic transmission: interplay with adenosine A2A receptors Hippocampus 17 2007 577 585
18. M.J. Diogenes, A.R. Costenla, L.V. Lopes, A. Jeronimo-Santos, V.C. Sousa, B.M. Fontinha, J.A. Ribeiro, and A.M. Sebastiao Enhancement of LTP in aged rats is dependent on endogenous BDNF Neuropsychopharmacology 36 2011 1823 1836
19. S.G. Dorsey, C.L. Renn, L. Carim-Todd, C.A. Barrick, L. Bambrick, B.K. Krueger, C.W. Ward, and L. Tessarollo In vivo restoration of physiological levels of truncated TrkB.T1 receptor rescues neuronal cell death in a trisomic mouse model Neuron 51 2006 21 28
20. F.F. Eide, E.R. Vining, B.L. Eide, K. Zang, X.Y. Wang, and L.F. Reichardt Naturally occurring truncated trkB receptors have dominant inhibitory effects on brain-derived neurotrophic factor signaling J. Neurosci. 16 1996 3123 3129
21. J. Espinosa, A. Rocha, F. Nunes, M.S. Costa, V. Schein, V. Kazlauckas, E. Kalinine, D.O. Souza, R.A. Cunha, and L.O. Porciuncula Caffeine consumption prevents memory impairment, neuronal damage, and adenosine A2A receptors upregulation in the hippocampus of a rat model of sporadic dementia J. Alzheimers Dis. 34 2013 509 518
22. I. Ferrer, C. Marin, M.J. Rey, T. Ribalta, E. Goutan, R. Blanco, E. Tolosa, and E. Marti BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies J. Neuropathol. Exp. Neurol. 58 1999 729 739
23. A. Figurov, L.D. Pozzo-Miller, P. Olafsson, T. Wang, and B. Lu Regulation of synaptic responses to high-frequency stimulation and LTP by neurotrophins in the hippocampus Nature 381 1996 706 709
24. B.M. Fontinha, M.J. Diogenes, J.A. Ribeiro, and A.M. Sebastiao Enhancement of long-term potentiation by brain-derived neurotrophic factor requires adenosine A2A receptor activation by endogenous adenosine Neuropharmacology 54 2008 924 933
25. B.B. Fredholm, A.P. IJzerman, K.A. Jacobson, K.N. Klotz, and J. Linden International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors Pharmacol. Rev. 53 2001 527 552
26. J. Hockemeyer, J.C. Burbiel, and C.E. Muller Multigram-scale syntheses, stability, and photoreactions of A2A adenosine receptor antagonists with 8-styrylxanthine structure: potential drugs for Parkinson's disease J. Org. Chem. 69 2004 3308 3318
27. R.M. Holsinger, J. Schnarr, P. Henry, V.T. Castelo, and M. Fahnestock Quantitation of BDNF mRNA in human parietal cortex by competitive reverse transcription-polymerase chain reaction: decreased levels in Alzheimer's disease Brain Res. Mol. Brain Res. 76 2000 347 354
28. M.F. Jarvis, R. Schulz, A.J. Hutchison, U.H. Do, M.A. Sills, and M. Williams [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain J. Pharmacol. Exp. Ther. 251 1989 888 893
29. Y. Ji, P.T. Pang, L. Feng, and B. Lu Cyclic AMP controls BDNF-induced TrkB phosphorylation and dendritic spine formation in mature hippocampal neurons Nat. Neurosci. 8 2005 164 172
30. S. Jin, and B.B. Fredholm Adenosine A2A receptor stimulation increases release of acetylcholine from rat hippocampus but not striatum, and does not affect catecholamine release Naunyn Schmiedeb. Arch. Pharmacol. 355 1997 48 56
31. S. Kemppainen, T. Rantamaki, A. Jeronimo-Santos, G. Lavasseur, H. Autio, N. Karpova, E. Karkkainen, S. Staven, H.V. Miranda, T.F. Outeiro, M.J. Diogenes, S. Laroche, S. Davis, A.M. Sebastiao, E. Castren, and H. Tanila Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice Neurobiol. Aging 33 1122 2012 e1123 1139
32. T.J. Kingsbury, P.D. Murray, L.L. Bambrick, and B.K. Krueger Ca(2+)-dependent regulation of TrkB expression in neurons J. Biol. Chem. 278 2003 40744 40748
33. M. Korte, P. Carroll, E. Wolf, G. Brem, H. Thoenen, and T. Bonhoeffer Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor Proc. Natl. Acad. Sci. U. S. A. 92 1995 8856 8860
34. F.S. Lee, and M.V. Chao Activation of Trk neurotrophin receptors in the absence of neurotrophins Proc. Natl. Acad. Sci. U. S. A. 98 2001 3555 3560
35. I.Y. Liu, W.E. Lyons, L.A. Mamounas, and R.F. Thompson Brain-derived neurotrophic factor plays a critical role in contextual fear conditioning J. Neurosci. 24 2004 7958 7963
36. B. Lu, G. Nagappan, X. Guan, P.J. Nathan, and P. Wren BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases Nat. Rev. Neurosci. 14 2013 401 416
37. M.A. Lynch Long-term potentiation and memory Physiol. Rev. 84 2004 87 136
38. S. Marques, V.L. Batalha, L.V. Lopes, and T.F. Outeiro Modulating Alzheimer's disease through caffeine: a putative link to epigenetics J. Alzheimers Dis. 24 Suppl. 2 2011 161 171
39. S.J. Martin, P.D. Grimwood, and R.G. Morris Synaptic plasticity and memory: an evaluation of the hypothesis Annu. Rev. Neurosci. 23 2000 649 711
40. M. Mayne, J. Fotheringham, H.J. Yan, C. Power, M.R. Del Bigio, J. Peeling, and J.D. Geiger Adenosine A2A receptor activation reduces proinflammatory events and decreases cell death following intracerebral hemorrhage Ann. Neurol. 49 2001 727 735
41. L. Minichiello, A.M. Calella, D.L. Medina, T. Bonhoeffer, R. Klein, and M. Korte Mechanism of TrkB-mediated hippocampal long-term potentiation Neuron 36 2002 121 137
42. A.H. Nagahara, D.A. Merrill, G. Coppola, S. Tsukada, B.E. Schroeder, G.M. Shaked, L. Wang, A. Blesch, A. Kim, J.M. Conner, E. Rockenstein, M.V. Chao, E.H. Koo, D. Geschwind, E. Masliah, A.A. Chiba, and M.H. Tuszynski Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease Nat. Med. 15 2009 331 337
43. M. Orru, C. Quiroz, X. Guitart, and S. Ferre Pharmacological evidence for different populations of postsynaptic adenosine A2A receptors in the rat striatum Neuropharmacology 61 2011 967 974
44. M. Orru, J. Bakesova, M. Brugarolas, C. Quiroz, V. Beaumont, S.R. Goldberg, C. Lluis, A. Cortes, R. Franco, V. Casado, E.I. Canela, and S. Ferre Striatal pre- and postsynaptic profile of adenosine A(2A) receptor antagonists PLoS One 6 2011 e16088
45. S.L. Patterson, T. Abel, T.A. Deuel, K.C. Martin, J.C. Rose, and E.R. Kandel Recombinant BDNF rescues deficits in basal synaptic transmission and hippocampal LTP in BDNF knockout mice Neuron 16 1996 1137 1145
46. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res. 29 2001 e45
47. H.S. Phillips, J.M. Hains, M. Armanini, G.R. Laramee, S.A. Johnson, and J.W. Winslow BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease Neuron 7 1991 695 702
48. P.A. Pousinha, M.J. Diogenes, J.A. Ribeiro, and A.M. Sebastiao Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors Neurosci. Lett. 404 2006 143 147
49. A. Rahman The role of adenosine in Alzheimer's disease Curr. Neuropharmacol. 7 2009 207 216
50. R. Rajagopal, Z.Y. Chen, F.S. Lee, and M.V. Chao Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes J. Neurosci. 24 2004 6650 6658
51. A.M. Sebastiao, N. Assaife-Lopes, M.J. Diogenes, S.H. Vaz, and J.A. Ribeiro Modulation of brain-derived neurotrophic factor (BDNF) actions in the nervous system by adenosine A(2A) receptors and the role of lipid rafts Biochim. Biophys. Acta 1808 2011 1340 1349
52. M.T. Sommerfeld, R. Schweigreiter, Y.A. Barde, and E. Hoppe Down-regulation of the neurotrophin receptor TrkB following ligand binding. Evidence for an involvement of the proteasome and differential regulation of TrkA and TrkB J. Biol. Chem. 275 2000 8982 8990
53. T. Spires-Jones, and S. Knafo Spines, plasticity, and cognition in Alzheimer's model mice Neural Plast. 2012 2012 319836
54. S. Takei, S. Morinobu, S. Yamamoto, M. Fuchikami, T. Matsumoto, and S. Yamawaki Enhanced hippocampal BDNF/TrkB signaling in response to fear conditioning in an animal model of posttraumatic stress disorder J. Psychiatr. Res. 45 2011 460 468
55. M.T. Tebano, A. Martire, R.L. Potenza, C. Gro, R. Pepponi, M. Armida, M.R. Domenici, M.A. Schwarzschild, J.F. Chen, and P. Popoli Adenosine A(2A) receptors are required for normal BDNF levels and BDNF-induced potentiation of synaptic transmission in the mouse hippocampus J. Neurochem. 104 2008 279 286
56. S.H. Vaz, T.N. Jorgensen, S. Cristovao-Ferreira, S. Duflot, J.A. Ribeiro, U. Gether, and A.M. Sebastiao Brain-derived neurotrophic factor (BDNF) enhances GABA transport by modulating the trafficking of GABA transporter-1 (GAT-1) from the plasma membrane of rat cortical astrocytes J. Biol. Chem. 286 2011 40464 40476
57. M. Yang, D. Soohoo, S. Soelaiman, R. Kalla, J. Zablocki, N. Chu, K. Leung, L. Yao, I. Diamond, L. Belardinelli, and J.C. Shryock Characterization of the potency, selectivity, and pharmacokinetic profile for six adenosine A2A receptor antagonists Naunyn Schmiedeb. Arch. Pharmacol. 375 2007 133 144